Table 5.
| A: Concordance of ERG protein status between intraductal carcinoma and invasive tumor | |||||
|---|---|---|---|---|---|
| ERG status of associated invasive tumor | |||||
| ERG negative |
ERG positive |
heterogeneous | |||
|
ERG status of intraductal carcinoma |
ERG negative | 16 | 0 | 1 | p<0.0001 |
| ERG positive | 0 | 24 | 1 | ||
| heterogeneous | 0 | 0 | 1 | ||
| 16 (37%) | 24 (56%) | 3 (7%) | |||
| B: Concordance of ERG protein status between intraductal cribriform proliferation and invasive tumor | |||||
|---|---|---|---|---|---|
| ERG status of associated invasive tumor | |||||
| ERG negative |
ERG positive |
heterogeneous | |||
|
ERG status of intraductal cribriform proliferation |
ERG negative | 5 | 0 | 0 | |
| ERG positive | 0 | 10 | 0 | p=0.0003 | |
| heterogeneous | 0 | 0 | 0 | ||
| 5 (33%) | 10 (66%) | 3 (7%) | |||
| C: Concordance of ERG protein status between high grade PIN and invasive tumor | |||||
|---|---|---|---|---|---|
| ERG status of associated invasive tumor | |||||
| ERG negative |
ERG positive |
heterogeneous | |||
|
ERG status of high grade PIN |
ERG negative | 16 | 10 | 0 | |
| ERG positive | 0 | 1 | 0 | p=NS | |
| heterogeneous | 3 | 0 | 0 | ||
| 19 (63%) | 11 (37%) | 0 (0%) | |||